Next Post

ROKIT Healthcare's Latest Paper About Its AI Technology Has Been Accepted to CVPR 2022

[ad_1] SEOUL, South Korea, March 15, 2022 /PRNewswire/ — ROKIT Healthcare, a world-wide hyper-customized organ regeneration business, declared on March 7th that its paper about the “AI and 3D bioprinting convergence engineering for regenerative therapies” has been approved to 2022 IEEE/CVF Convention on Computer Eyesight and Sample Recognition (CVPR). CVPR […]

You May Like